Table of Contents

company-logo

Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. Its products include BCX-CM-J, a stem-cell based biological drug for the treatment of degenerative joint lesions in dogs; BCX-CM-AD, a biological drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a biological drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was incorporated in 2018 and is based in Wroclaw, Poland.

Bioceltix Dividend Announcement

• Bioceltix does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Bioceltix dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Bioceltix Dividend History

Bioceltix Dividend Yield

Bioceltix current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Bioceltix stock? Use our calculator to estimate your expected dividend yield:

Bioceltix Financial Ratios

P/E ratio-20.94
PEG ratio-0.21
P/B ratio7.33
ROE-82.90%
Payout ratio0.00%
Current ratio3.27
Quick ratio3.27
Cash Ratio2.87

Bioceltix Dividend FAQ

Does Bioceltix stock pay dividends?
Bioceltix does not currently pay dividends to its shareholders.
Has Bioceltix ever paid a dividend?
No, Bioceltix has no a history of paying dividends to its shareholders. Bioceltix is not known for its dividend payments.
Why doesn't Bioceltix pay dividends?
There are several potential reasons why Bioceltix would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Bioceltix ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Bioceltix has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Bioceltix a dividend aristocrat?
Bioceltix is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Bioceltix a dividend king?
Bioceltix is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Bioceltix a dividend stock?
No, Bioceltix is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Bioceltix stocks?
To buy Bioceltix you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Bioceltix stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.